Skip to main content
. 2022 Jan 13;8:756398. doi: 10.3389/fmed.2021.756398

Table 3.

Adverse events in the atropine groups vs control group during the treatment of myopia in children.

Outcomes No. of studies No. of patients Odds Ratio
(95% CI)
I2
Photophobia 5 RCTs 388/1,757 vs. 15/2,325 16.69
(5.37–51.9)
70.7%
9 Cohort
Blurred near vision 4 RCTs 144/1,633 vs. 0 17.16
(7.97, 36.95)
0
6 Cohort
Allergy 5 RCTs 49/1,387 vs. 21/1,483 2.24
(1.37–3.64)
77.0%
2 Cohort